Form 4: Danaher EVP McGrew Granted RSUs and Stock Options

Danaher Corporation's Executive Vice President Matthew McGrew received grants of restricted stock units and employee stock options, effective March 1, 2026.

Summary

• Matthew McGrew, Executive Vice President of Danaher Corporation (DHR), was granted 5,935 restricted stock units (RSUs).
• These RSUs are payable solely in common stock and will vest 25% on each of the first four anniversaries of the grant date, March 1, 2026.
• Following this transaction, McGrew beneficially owns 26,825 shares of common stock directly and 10,238.635 shares indirectly through a 401(k) plan.
• McGrew was also granted 16,039 employee stock options with an exercise price of $210.64.
• Fifty percent of these options will become exercisable on the third anniversary of the grant date (March 1, 2026), and the remaining 50% on the fourth anniversary.
• The options have an expiration date of March 1, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational or financial shifts.

Positives

• The grants align executive incentives with long-term shareholder value through equity ownership and performance-based vesting schedules.
• The acquisition of additional equity by a key executive demonstrates continued commitment to the company's future performance.

Future Outlook

The grants of restricted stock units and stock options, with their multi-year vesting and exercisability schedules, indicate a long-term incentive structure designed to align executive interests with the company's sustained performance over the coming years.

Industry Context

StockSavvy.ai notes that the granting of restricted stock units and stock options to key executives is a standard practice in the life sciences and diagnostics industry, as well as broader corporate America, to attract, retain, and motivate top talent while aligning their interests with long-term shareholder value. This type of compensation is common across companies like Thermo Fisher Scientific (TMO) and Abbott Laboratories (ABT).

Comparison to Industry Standards

• The use of RSUs and stock options for executive compensation is a widely adopted practice, consistent with global benchmarks for large-cap companies in the industrial and healthcare sectors.
• The multi-year vesting schedules (four years for RSUs, three to four years for options) are typical for long-term incentive plans, comparable to those observed at peer companies such as Siemens Healthineers AG and Agilent Technologies, Inc.

Related Party Transactions

• The grants of restricted stock units and employee stock options to Executive Vice President Matthew McGrew constitute related party transactions, as they involve compensation from the company to a key executive.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance and shareholder value creation.
• Employees (Matthew McGrew): Direct positive impact through significant equity-based compensation, enhancing personal wealth and long-term financial incentives.

Next Steps

• The restricted stock units will vest 25% annually on the first four anniversaries of March 1, 2026.
• Fifty percent of the employee stock options will become exercisable on the third anniversary of March 1, 2026, and the remaining 50% on the fourth anniversary.

Key Dates

Keywords

Danaher, DHR, Matthew McGrew, Restricted Stock Units, RSUs, Stock Options, Executive Compensation, Insider Transaction, Equity Grant